Clinical trial

Mid-Q Response Study

NCT04180696

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2020-01-23

PhaseNA

Study timeline

Study start (actual)2020-01-23Date precision: day

Registry last updated2025-07-09

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Heart Failureunresolved

Left Bundle-Branch Blockunresolved

Heart Failure With Reduced Ejection Fraction (HFrEF)unresolved

Heart Failure NYHA Class IIunresolved

Heart Failure NYHA Class IIIunresolved

Heart Failure NYHA Class IVunresolved

Interventions

Sponsors & collaborators

Medtronic Cardiac Rhythm and Heart Failurelead sponsor

Medtroniccollaborator

Medtronic Japan Co., Ltd.collaborator

Mapped research locations

SeoulSouth Korea7 SingaporeSingapore3 Hong KongHong Kong3 TokyoJapan2 OsakaJapan2 OkayamaJapan2 ShanghaiChina1 TaichungTaiwan1 Kaohsiung CityTaiwan1 TainanTaiwan1 FukuokaJapan1 DaeguSouth Korea1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04180696 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.